Simplex Trading’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.22M Sell
51,300
-152,000
-75% -$10.6M ﹤0.01% 1440
2025
Q4
$13.5M Sell
203,300
-20,800
-9% -$1.34M 0.01% 699
2025
Q3
$15.1M Buy
224,100
+58,200
+35% +$4.61M 0.01% 748
2025
Q2
$14.5M Buy
165,900
+14,400
+10% +$1.13M 0.01% 680
2025
Q1
$10.3M Sell
151,500
-242,600
-62% -$19.8M 0.01% 870
2024
Q4
$30.6M Buy
394,100
+191,000
+94% +$14.1M 0.02% 456
2024
Q3
$13.6M Buy
203,100
+36,000
+22% +$2.96M 0.01% 846
2024
Q2
$18.9M Sell
167,100
-128,000
-43% -$16.2M 0.01% 641
2024
Q1
$40.9M Sell
295,100
-194,800
-40% -$24.5M 0.02% 394
2023
Q4
$60.8M Buy
489,900
+137,700
+39% +$14.1M 0.04% 286
2023
Q3
$32.9M Buy
352,200
+135,200
+62% +$15.2M 0.03% 406
2023
Q2
$27.9M Buy
217,000
+75,500
+53% +$9.13M 0.02% 441
2023
Q1
$16.4M Sell
141,500
-113,200
-44% -$12.7M 0.01% 667
2022
Q4
$28.8M Buy
254,700
+164,500
+182% +$18.1M 0.03% 427
2022
Q3
$7.26M Sell
90,200
-98,200
-52% -$8.32M 0.01% 953
2022
Q2
$14M Buy
188,400
+101,200
+116% +$9.24M 0.01% 650
2022
Q1
$11.2M Sell
87,200
-9,600
-10% -$1.05M 0.01% 780
2021
Q4
$13M Sell
96,800
-14,800
-13% -$2.13M 0.01% 675
2021
Q3
$11.9M Buy
111,600
+400
+0.4% +$50.4K 0.01% 652
2021
Q2
$11.9M Buy
111,200
+109,704
+7,333% +$10.5M 0.01% 642
2021
Q1
$13.4M Buy
1,496
+272
+22% +$25.5K 0.02% 371
2020
Q4
$11.3M Buy
1,224
+656
+115% +$58.6K 0.01% 532
2020
Q3
$5.85M Sell
568
-540
-49% -$56.4K 0.01% 773
2020
Q2
$11.2M Buy
1,108
+740
+201% +$66.2K 0.02% 481
2020
Q1
$2.48M Sell
368
-608
-62% -$37.8K ﹤0.01% 1120
2019
Q4
$5.34M Buy
976
+624
+177% +$29.6K 0.01% 763
2019
Q3
$1.31M Buy
352
+100
+40% +$3.88K ﹤0.01% 1688
2019
Q2
$943K Sell
252
-1,384
-85% -$43.5K ﹤0.01% 1954
2019
Q1
$4.87M Buy
1,636
+1,536
+1,536% +$54K 0.01% 698
2018
Q4
$299K Buy
100
+20
+25% +$634 ﹤0.01% 2723
2018
Q3
$286K Sell
80
-612
-88% -$19K ﹤0.01% 3237
2018
Q2
$1.64M Sell
692
-88
-11% -$1.87K 0.01% 1314
2018
Q1
$109K Buy
780
+264
+51% +$3.9K ﹤0.01% 1739
2017
Q4
$117K Sell
516
-584
-53% -$7.59K 0.01% 1676
2017
Q3
$46K Buy
1,100
+912
+485% +$16.1K ﹤0.01% 2372
2017
Q2
$5K Sell
188
-332
-64% -$6.13K ﹤0.01% 4567
2017
Q1
$63K Sell
520
-280
-35% -$5.46K ﹤0.01% 2150
2016
Q4
$15K Sell
800
-940
-54% -$16.7K ﹤0.01% 3306
2016
Q3
$226K Buy
1,740
+1,692
+3,525% +$37.7K 0.02% 941
2016
Q2
$9K Sell
48
-48
-50% -$817 ﹤0.01% 3676
2016
Q1
$9K Sell
96
-92
-49% -$1.54K ﹤0.01% 3559
2015
Q4
$5K Sell
188
-580
-76% -$12.1K ﹤0.01% 3852
2015
Q3
$44K Buy
768
+604
+368% +$13.5K ﹤0.01% 2096
2015
Q2
$16K Buy
+164
New +$2.88K ﹤0.01% 2655
2015
Q1
Sell
-8
Closed -$5K 5055
2014
Q4
$5K Buy
+8
New +$98 ﹤0.01% 3068

Other funds holding DXCM

Simplex Trading's DXCM Position: Q1 2026 in Review

Simplex Trading opened a new position in DexCom (DXCM) in Q1 2026: 5,052 shares worth $317K. The stake represents ﹤0.01% of the portfolio and ranks #3768 among its holdings. This is a return to the name: Simplex Trading previously reported a position in DXCM as recently as Q2 2025.

Simplex Trading first reported a position in DXCM in Q1 2015 and has held it in 27 quarters since. The position peaked at $4.41M in Q4 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Simplex Trading held 5,052 shares of DexCom worth $317K as of Q1 2026.
  • DexCom was a new Simplex Trading position in Q1 2026.
  • DexCom made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #3768 holding.
  • Simplex Trading first reported a position in DexCom in Q1 2015 and has held it in 27 quarters since.
  • Simplex Trading's DexCom position peaked at $4.41M in Q4 2024.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.